INS and type 2 diabetes mellitus: Many patients with type 2 diabetes use metformin, sulfonylurea (SU) derivatives, insulin, ACE inhibitors, angiotensin II receptor blockers (ARB) and statins to reduce the vascular complication risk.1 Some mechanisms of action of these agents are not completely understood.